Transfection of Human CD80 Gene into Glioma Cell Line U251

Xue ZHANG,Jing-ming LIN,Xiao-dan JIANG,Hong-wei MA,Kun QIN,Ai-lin GUO,Yu LIU
DOI: https://doi.org/10.3760/cma.j.issn.1671-8925.2007.04.001
2007-01-01
Abstract:Objective To construct the eukaryotic expression vector of human CD80 gene,then transfect it into glioma cell line U251 and to detect its expression in transfected U251 cells.Methods The open reading frame(ORF)of human CD80 was amplified by PCR,digested by restriction enzyme and connected into eukaryotic expression vector pcDNA3,h The recombinant plasmid pcDNA3.1/CD80 was identified by double restriction enzyme digestion and sequencing.The plasmid was transferred into U251 cells by liposome.The expression of CD80 gene in the transfected U251 cells was detected by immunocytochemistry,flow cytometry,RT-PCR and Western blotting,respectively.Results CD80 fragment of about 900 bp from pcDNA3.1/CD80 could be obtained by double restriction enzyme digestion,which was confirmed by sequencing.Numerous green fluorescent cells were observed under fluorescence microscope,and the transfection efficiency was 31.8%.The expression ofCD80 mRNA was detected by RT-PCR,and the target protein band of about 60 kD was showed by Western blotting. Conclusion The pcDNA3.1/CD80 expression vector has been successfully constructed and expressed in glioma cell line U251,which provides significant evidence for researching the immunogenicity of genetically engineered tumor cells,as well as for producing the vaccine of glioma.
What problem does this paper attempt to address?